← Back to graph
Theory

Big Pharma cancer cure suppression

Big Pharma cancer cure suppression

Summary

Headline Finding:

Laetrile, derived from apricot kernels, is claimed by alternative medicine proponents as an effective cancer treatment that has been suppressed by pharmaceutical interests due to its inability to be patented. However, mainstream science and regulatory bodies like the FDA have rejected these claims based on lack of credible evidence and concerns over toxicity.

Key Findings:

  • Laetrile, or Vitamin B-17, is claimed to target and kill cancer cells through a mechanism involving enzymes Rhodanese (present in normal cells) and Beta-Glucosidase (found only in cancer cells), releasing cyanide and benzaldehyde that destroy cancer cells [1][2].
  • Despite anecdotal evidence of successful treatment with Laetrile, the FDA has not approved its use due to concerns over toxicity and lack of clinical trial evidence showing efficacy [1][2].
  • The pharmaceutical industry is argued to have no incentive to cure diseases like cancer because it generates substantial revenue from ongoing treatments; the global oncology market is expected to reach $311.81 billion by 2032 [3].
  • Significant advancements in cancer treatment include targeted therapies, immunotherapies, and personalized medicine approaches, which are continuously developed through extensive clinical trials following strict ethical standards [4][10].

Disagreements:

  • Alternative medicine proponents claim that Laetrile is an effective cancer treatment suppressed by pharmaceutical interests for financial reasons, while mainstream science rejects these claims due to lack of credible evidence and concerns over toxicity [1][2][3][4].
  • The conspiracy theory that Big Pharma suppresses a universal cure for cancer is widely debunked; experts argue the complexity and diversity of cancer make such suppression statistically impossible given the number of people involved in medical research [6].

Open Questions:

  • What specific mechanisms are used by pharmaceutical companies to delay generic drug availability, and how do these practices impact patient access to affordable treatments?
  • How can regulatory bodies balance the need for rigorous clinical trials with the urgency of providing patients with potentially life-saving alternative treatments like Laetrile?

Sources

Per-source notes

B-17 / Laetrile: Alternative Cancer Treatment Suppressed

<https://www.chrisbeatcancer.com/b17-laetrile-alternative-cancer-treatment-suppressed-50-years/>

  • Laetrile, or Vitamin B-17, is a natural substance claimed to target and kill cancer cells without harming healthy tissue.
  • The mechanism involves enzymes Rhodanese (present in normal cells) and Beta-Glucosidase (found only in cancer cells). Cancer cells lack Rhodanese, which neutralizes toxic components of B-17, leading to the release of cyanide and benzaldehyde that kill these cells.
  • Foods rich in B-17 include apricot kernels, bitter almonds, and seeds from various fruits. Recommended intake is 1-2 kernels per 10 lbs of body weight daily.
  • Laetrile was studied extensively but suppressed by pharmaceutical interests due to its inability to be patented and monetized.
  • Key figures like Dr. Sugiura found positive results in studies on Laetrile, but these were discredited by the medical establishment for reasons that some attribute to financial motives.
  • Despite FDA non-approval, Laetrile is still used in alternative cancer treatments outside the U.S., such as at Oasis of Hope Hospital in Mexico.

Shaky Claims:

  • The article makes strong claims about suppression and corruption within the pharmaceutical industry without providing concrete evidence or sources for these assertions.

Laetrile From Apricot Seeds: The Cancer Cure Suppressed by Big Pharma

<https://healthimpactnews.com/2017/laetrile-from-apricot-seeds-the-cancer-cure-suppressed-by-big-pharma/>

Most Useful Fact: Laetrile, derived from apricot kernels and rich in amygdalin, has shown potential in treating cancer through its unique mechanism of releasing cyanide specifically within cancer cells.

  • Mechanism: Amygdalin contains glucose, benzaldyhide (with anti-cancer properties), and cyanide. Cancer cells attract the compound for its glucose but are destroyed when enzymes release the toxic components.
  • FDA Ban: Laetrile is banned in the USA by the FDA, though it's used in Mexican clinics.
  • Anecdotal Evidence: Many cancer patients report successful treatment with apricot kernels or laetrile, including Paul Reid who went into remission after refusing chemotherapy and consuming 30 apricot kernels daily.
  • Scientific Studies:

- A German study (2014) showed amygdalin reduced bladder cancer growth. - Research indicates it may inhibit kidney fibrosis and induce apoptosis in cervical and prostate cancers.

  • Toxicity Concerns: While cyanide is a concern, the compound is metabolized safely by healthy cells.
  • Historical Context: The Sloan-Kettering Cancer Center suppressed positive findings on laetrile's efficacy due to potential economic impacts on pharmaceutical companies.

The answers to different cancers aren’t ever coming from Big Pharma!

<https://nofakenews.net/2025/09/19/the-answers-to-different-cancers-arent-ever-coming-from-big-pharma/>

Most Useful Fact: The pharmaceutical industry profits immensely from ongoing cancer treatments, with the global oncology/cancer drugs market expected to reach $311.81 billion by 2032.

  • Dr. John Reizer argues that Big Pharma has no incentive to cure diseases like cancer because it generates substantial revenue.
  • Biologic drugs average around $3,000 per month and chemotherapy can cost up to $65,000 monthly.
  • Researchers Murphy and Topel estimate the value of curing cancer at nearly $50 trillion (2006 figures).
  • Mainstream media often supports pharmaceutical companies by presenting three common defenses:

- The vast number of scientists involved would prevent suppression. - Drug companies benefit from long-term patient management rather than cures. - Cancer is not a single disease but many, making a universal cure impossible.

  • Reizer counters these points, suggesting compartmentalization and profit motives override ethical concerns.
  • He claims that cancers stem from dysfunctional physiology caused by various interferences, including pharmaceuticals and engineered products.
  • The film "Target List" explores the idea of Big Pharma suppressing cancer cures for financial gain.

Shaky Claims:

  • Assertions about population control and resets are speculative and lack concrete evidence.

Big Pharma and Cancer: Debunking the Hidden Cure Myth | Treatment Advances

<https://www.factualamerica.com/conspiracy-critic/miracle-cures-or-market-manipulation-unraveling-big-pharmas-cancer-conundrum>

Most Useful Fact: There is no credible evidence that Big Pharma intentionally suppresses a cure for cancer.

  • Complexity of Cancer: The idea that pharmaceutical companies are suppressing a universal cure overlooks the complexity and diversity of cancer as a group of diseases.
  • Significant Advancements: Pharmaceutical companies have made significant strides in developing targeted therapies, immunotherapies, and personalized medicine approaches to improve patient outcomes.
  • Clinical Trials and Evidence-Based Medicine:

- Clinical trials follow strict ethical and scientific standards to ensure safety and efficacy before FDA approval. - Placebo controls and blinding methods are used to minimize bias and provide reliable results.

  • Recent Breakthroughs: Precision medicine, CAR-T cell therapy, liquid biopsies, and immunotherapy have revolutionized cancer treatment.
  • Patents and Drug Availability:

- Patents grant exclusivity but can be extended through minor modifications (evergreening), delaying generic availability. - Patent expirations lead to biosimilar development, potentially increasing accessibility.

  • Profit Motives: Pharmaceutical companies invest billions in R&D with profit motives; cancer drugs are particularly lucrative and often priced high.
  • Funding Sources:

- Cancer research is funded by government grants, private foundations, pharmaceutical companies, and academic institutions. - Public-private partnerships aim to balance commercial interests with public health needs.

Flagged Claims: The article does not provide specific examples of evergreening practices or quantify the impact on drug availability.

Royal Rife - Wikipedia

<https://en.wikipedia.org/wiki/Royal_Rife>

Royal Raymond Rife claimed his microscopes could observe live microorganisms at magnifications considered impossible for his time and that his "oscillating beam ray" device could treat diseases by destroying pathogens with radio waves. However, mainstream science has rejected these claims.

  • Rife's supporters claim electromagnetic frequencies can disable cancerous cells and other disease-causing microorganisms.
  • Rife machines are not approved by health regulators and have been linked to health fraud cases.
  • Multiple promoters of Rife devices have been convicted of health fraud and imprisoned.
  • Claims about Rife’s inventions lack scientific backing, and Cancer Research UK states there is no reliable evidence that Rife machines work as a cure for cancer.

Key points:

  • Rife invented microscopes with claimed magnifications up to 17,000×.
  • He reported observing microbes changing forms under certain conditions.
  • His "beam ray" device purportedly destroyed pathogens by vibrating them at specific frequencies.
  • After his death in 1971, interest in Rife's claims was revived by conspiracy theories and alternative medical circles.
  • Devices marketed as Rife machines have been linked to deaths among cancer patients who stopped conventional treatment.

Busting the conspiracy – is there a hidden cure for cancer?

<https://www.cclg.org.uk/news-updates/busting-conspiracy-is-there-hidden-cure-cancer>

  • The "hidden cure for cancer" conspiracy theory is false; experts explain why such a cure would be statistically impossible to keep secret given the number of people involved in medical research.

Key points:

  • Cancer is not one disease but over 200, each with different origins and behaviors.
  • Scientific breakthroughs often lack context when reported, leading to misconceptions about progress.
  • Developing new medicines takes 10-15 years due to extensive testing required for safety and efficacy.
  • Statistically, a cure would be hard to hide; researcher David Robert Grimes estimated that over 700,000 people could be involved in pharmaceutical companies alone.
  • Pharmaceutical companies have more to gain from curing patients as it secures long-term customers rather than short-term treatments.

cancer cure — Conspiracy Theories | Conspiracy Theory Wiki

<https://conspiracytheory.net/tag/cancer-cure/>

  • The conspiracy theory that pharmaceutical companies suppress effective cancer cures is widely debunked.

Key points:

  • Royal Raymond Rife: In the 1930s, he claimed his frequency device could destroy cancer cells. Allegations suggest the American Medical Association (AMA) suppressed his work.
  • Rife Machine Claims: Modern analysis shows no scientific basis for these devices to cure cancer.
  • Linus Pauling and Vitamin C: Pauling proposed high-dose vitamin C as a cancer treatment, but controlled clinical trials by Charles Moertel at the Mayo Clinic debunked this claim.

Other details:

  • Theories often involve individuals like Stanislaw Burzynski and Morris Fishbein.
  • Specific time periods mentioned include the 1930s for Rife and 1971 for Pauling's vitamin C claims.

Rotary Club of Delhi Divine Hosts Talk Debunking Cancer Myths - India CSR

<https://indiacsr.in/rotary-club-delhi-divine-cancer-awareness-health-talk/>

  • Dr. Amish Vora, Director of HOPE Oncology Clinic, debunked the myth that pharmaceutical companies suppress cancer cures.

Key points from Dr. Vora's talk:

  • Cancer is not one disease but a group of hundreds of diseases.
  • No evidence supports the claim that Big Pharma intentionally suppresses cancer cures; researchers worldwide are continuously working on better treatments and cures.
  • Maintaining a positive mindset during illness can help patients recover better, according to Rotarian CS Aditya Rungta.
  • Lifestyle changes such as brisk walking five times a week and maintaining eight hours of sleep daily can reduce the risk of cancer.

Event details:

  • Organized by Rotary Club of Delhi Divine under President Rotarian CS Aditya Rungta.
  • Over 50 members participated in the event held at Dr. Bhasin’s Lab, Greater Kailash–1, New Delhi.
  • The session was interactive, with attendees asking questions about cancer myths, prevention, treatment, and patient care.

No specific claims were made that appeared shaky or unsourced; however, the article lacks detailed references to support some of the health recommendations.

Types of Cancer Treatment

<https://www.cancer.gov/about-cancer/treatment/types>

  • The article lists several types of cancer treatments available depending on the type and stage of cancer.
  • Treatments include:

- Chemotherapy: Kills or stops fast-growing cells including cancer cells. - Hormone Therapy: Slows or stops growth in hormone-dependent cancers like breast and prostate. - Hyperthermia: Heats body tissue to damage and kill cancer cells. - Immunotherapy: Assists the immune system in fighting cancer. - Photodynamic Therapy: Uses light-activated drugs to destroy abnormal cells. - Radiation Therapy: Kills cancer cells with high doses of radiation. - Blood Stem Cell Transplant: Replaces blood-forming stem cells damaged by chemotherapy or radiation. - Cancer Surgery: Surgical removal of tumors and cancerous tissues. - Targeted Therapy: Targets specific changes in cancer cells to inhibit growth, division, and spread.

  • Most patients receive a combination of these treatments rather than just one.

The ultra-fast cancer treatments which could replace conventional radiotherapy

<https://www.bbc.com/future/article/20250121-the-physics-transforming-cancer>

  • Flash therapy delivers ultra-high dose radiation in less than a second, potentially curing complex brain tumors and metastasized cancers with fewer side effects compared to conventional radiotherapy.
  • Developed at CERN, Flash therapy has shown promise in animal studies for treating various types of cancer while sparing healthy tissue.
  • Human trials are underway, including one at Cincinnati Children's Hospital targeting pediatric patients with metastatic cancer affecting chest bones.
  • Protons have been the primary particle used in human trials due to their deep penetration capability and ease of adaptation from existing proton therapy machines.
  • Challenges include the large size and high cost of current Flash delivery systems, limiting accessibility. Research is ongoing to develop smaller, more affordable accelerators for wider use.
  • The potential benefits could extend to treating metastatic cancers and complex tumors like glioblastoma, with hopes that newer accelerators will make Flash therapy accessible in standard hospitals.
  • Addressing the global "radiotherapy gap," where sub-Saharan Africa has only 195 radiotherapy machines compared to 4,172 in the US and Canada, is a key goal for improving cancer treatment worldwide.

--- _Generated locally by ClaudeClaw research on Spark 2_ _Topic row #70 in claudeclaw.db on dgx2_

--- _Synthesized from open-web sources on 2026-05-18. Node in conspiracyg knowledge graph. Showing the connections, not the verdict._

Connections

No connections recorded yet.

Sources

Local graph